PDF (311.4 KB)
Collect
Submit Manuscript
Erratum

Erratum to: Selenopeptide nanomedicine ameliorates atherosclerosis by reducing monocyte adhesions and inflammations

Zhen Luo1,3,§Yuxing Jiang1,4,§Zimo Liu1,2,5,§Lamei Guo1,6,§Li Zhang1,6Hongtao Rong4Zhongyu Duan3Hongwen Liang7Aili Zhang8Lei Wang1,5Yu Yi1,5()Hao Wang1,2,5()
CAS Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology (NCNST), No. 11 Beiyitiao, Zhongguancun, Beijing 100190, China
Sino-Danish College, Sino-Danish Center for Education and Research, University of Chinese Academy of Sciences, Beijing 100049, China
School of Chemical Engineering and Technology, Hebei University of Technology, Tianjin 300130, China
Tianjin Medical University General Hospital, Tianjin 300052, China
University of Chinese Academy of Sciences, Beijing 100049, China
School of Environmental Science and Safety Engineering, Tianjin University of Technology, Tianjin 300384, China
College of Pharmacy, Chongqing Medical University, Chongqing 400016, China
School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China

§ Zhen Luo, Yuxing Jiang, Zimo Liu, and Lamei Guo contributed equally to this work.

Show Author Information
The online version of the original article can be found at:

Nano Research
Article number: 94907396
Cite this article:
Luo Z, Jiang Y, Liu Z, et al. Erratum to: Selenopeptide nanomedicine ameliorates atherosclerosis by reducing monocyte adhesions and inflammations. Nano Research, 2025, 18(4): 94907396. https://doi.org/10.26599/NR.2025.94907396
Metrics & Citations  
Article History
Copyright
Rights and Permissions
Return